Formation of preβ1-HDL during lipolysis of triglyceride-rich lipoprotein

Biochemical and Biophysical Research Communications

Volumn 379, Issue 1, 2009, Pages 55-59

  Miyazaki, Osamu ^a   Fukamachi, Isamu ^a   Mori, Atsuo ^a   Hashimoto, Hideyuki ^a   Kawashiri, Masa aki ^b   Nohara, Atsushi ^b   Noguchi, Tohru ^b   Inazu, Akihiro ^b   Yamagishi, Masakazu ^b   Mabuchi, Hiroshi ^b   Kobayashi, Junji ^b  

^a SEKISUI CHEMICAL CO LTD   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Lipoprotein lipase; Pre HDL; Triglyceride rich lipoprotein; Very low density lipoprotein

Indexed keywords

ALPHA HDL; FATTY ACID; HEPARIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PREBETA1 HDL; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; PRE BETA HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; COW; FAST PROTEIN LIQUID CHROMATOGRAPHY; GEL FILTRATION; HEPARIN BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; INCUBATION TIME; INJECTION; LIPOLYSIS; LIPOPROTEIN LIPASE BLOOD LEVEL; MALE; MILK; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION; VERY LOW DENSITY LIPOPROTEIN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; CATTLE; METABOLISM; MIDDLE AGED;

BOVINAE; DISCOIDAE;

ADULT; ANIMALS; CATTLE; HEPARIN; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; LIPOLYSIS; MALE; MIDDLE AGED; MILK; TRIGLYCERIDES;

EID: 58149302676     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.146     Document Type: Article

References (33)

1. Castro G.R., and Fielding C.J. Early incorporation of cell-derived cholesterol into pre-beta-migrating high density lipoprotein. Biochemistry 27 (1988) 25-29
2. Barrans A., Jaspard B., Barbaras R., Chap H., Perret B., and Collet X. Pre-β HDL: structure and metabolism. Biochim. Biophys. Acta 1300 (1996) 73-85
3. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36 (1995) 211-228
4. Asztalos B.F., Sloop C.H., Wong L., and Roheim P.S. Comparison of apoA-I-containing subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration in subpopulations in the interstitial space. Biochim. Biophys. Acta 1169 (1993) 301-304
5. Dixon J.L., and Ginsberg H.N. Hepatic synthesis of lipoproteins and apolipoproteins. Semin. Liver Dis. 12 (1992) 364-372
6. Castle C.K., Pape M.E., Marotti K.R., and Melchior G.W. Secretion of pre-beta-migrating apoA-I by cynomolgus monkey hepatocytes in culture. J. Lipid Res. 32 (1991) 439-447
7. Danielsen E.M., Hansen G.H., and Poulsen M.D. Apical secretion of apolipoproteins from enterocytes. J. Cell. Biol. 120 (1993) 1347-1356
8. Rye K.A., Clay M.A., and Barter P.J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145 (1999) 227-238
9. Westhuyzen v.d.D.R., Beer d.F.C., and Webb N.R. HDL cholesterol transport during inflammation. Curr. Opin. Lipidol. 18 (2007) 147-151
10. Sviridov D., and Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161 (2002) 245-254
11. Chau P., Nakamura Y., Fielding C.J., and Fielding P.E. Mechanism of prebeta-HDL formation and activation. Biochemistry 45 (2006) 3981-3987
12. Duong P.T., Weibel G.L., Lund-Katz S., Rothblat G.H., and Phillips M.C. Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I. J. Lipid Res. 49 (2008) 1006-1014
13. Schaefer E.J., Wetzel M.G., Bengtsson G., Scow R.O., Brewer Jr. H.B., and Olivecrona T. Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis. J. Lipid Res. 23 (1982) 1259-1273
14. Glickman R.M., Green P.H., Lees R.S., and Tall A. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. N. Engl. J. Med. 299 (1978) 1424-1427
15. Schonfeld G., Bell E., and Alpers D.H. Intestinal apoproteins during fat absorption. J. Clin. Invest. 61 (1978) 1539-1550
16. Tall A.R., Green P.H., Glickman R.M., and Riley J.W. Metabolic fate of chylomicron phospholipids and apoproteins in the rat. J. Clin. Invest. 64 (1979) 977-989
17. Schaefer E.J., Jenkins L.L., and Brewer Jr. H.B. Human chylomicron apolipoprotein metabolism. Biochem. Biophys. Res. Commun. 80 (1978) 405-412
18. O'Connnor P.J., Naya-Vigne P., Duchateau B., Ishida M., Mazur B., Zysow M., Malloy S., Kunitake S., and Kane J. Measurement of pre beta-1 HDL in human plasma by ultrafiltration-isotope dilution technique. Anal. Biochem. 251 (1997) 234-240
19. Nanjee M.N., and Brinton E.A. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography. Clin. Chem. 46 (2000) 207-223
20. Miyazaki O., Kobayashi J., Fukamachi I., Miida T., Bujo H., and Saito Y. A new sandwich enzyme immunoassay for measurement of plasma pre-beta1-HDL levels. J. Lipid Res. 41 (2000) 2083-2088
21. Miida T., Miyazaki O., Nakamura Y., Hirayama S., Hanyu O., Fukamachi I., and Okada M. Analytical performance of a sandwich enzyme immunoassay for preβ1-HDL in stabilized plasma. J. Lipid Res. 44 (2003) 645-650
22. Kobayashi J., Hashimoto H., Fukamachi I., Tashiro J., Shirai K., Saito Y., and Yoshida S. Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin. Chim. Acta 216 (1993) 113-123
23. Neary R., Bhatnagar D., Durrington P., Ishola M., Arrol S., and Mackness M. An investigation of the role of lecithin:cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins. Atherosclerosis 89 (1991) 35-48
24. Hattori H., Kujiraoka T., Egashira T., Saito E., Fujioka T., Takahashi S., Ito M., Cooper J.A., Stepanova I.P., Nanjee M.N., and Miller N.E. Association of coronary heart disease with pre-beta-HDL concentrations in Japanese men. Clin. Chem. 50 (2004) 589-595
25. Miida T., Nakamura Y., Inano K., Matsuto T., Yamaguchi T., Tsuda T., and Okada M. Preβ1-high density lipoprotein increases in coronary artery disease. Clin. Chem. 42 (1996) 1992-1995
26. Asztalos B.F., Roheim P.S., Milani R.L., Lefevre M., McNamara J.R., Horvath K.V., and Schaefer E.J. Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2670-2676
27. 2: a study comparing liver perfusion to in vitro incubation with lipases. J. Biol. Chem. 269 (1994) 11572-11577
28. Miida T., Sakai K., Ozaki K., Nakamura Y., Yamaguchi T., Tsuda T., Kashiwa T., Murakami T., Inano K., and Okada M. Bezafibrate increases preβ1-HDL at the expense of HDL2b in hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2428-2433
29. Troutt J.S., Alborn W.E., Mosior M.K., Dai J., Murphy A.T., Beyer T.P., Zhang Y., Cao G., and Konrad R.J. An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma. J. Lipid Res. 49 (2008) 581-587
30. Glomset J.A. The lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9 (1968) 155-167
31. Francone O.L., Gurakar A., and Fielding C. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J. Biol. Chem. 264 (1989) 7066-7072
32. Miida T., Obayashi K., Seino U., Zhu Y., Ito T., Kosuge K., Hirayama S., Hanyu O., Nakamura Y., Yamaguchi T., Tsuda T., Saito Y., Miyazaki O., Nakamura Y., and Okada M. LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy Japanese. Clin. Chim. Acta 350 (2004) 107-114
33. Miida T., Miyazaki O., Hanyu O., Nakamura Y., Hirayama S., Narita I., Gejyo F., Ei I., Tasaki K., Kohda Y., Ohta T., Yata S., Fukamachi I., and M.Okada. LCAT-dependent conversion of preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients. J. Am. Soc. Nephrol. 14 (2003) 732-738